Cite

HARVARD Citation

    Lai, C. et al. (2016). Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong. Alimentary pharmacology & therapeutics. 43 (1), pp. 96-101. [Online]. 
  
Back to record